Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
wright1196964577.pdf (4.31 MB)
ETD Abstract Container
Abstract Header
ORAL LD50 OF BOTULINUM TOXIN SEROTYPE A IN GUINEA PIGS
Author Info
Wilhelm, Christina Marie
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=wright1196964577
Abstract Details
Year and Degree
2007, Master of Science (MS), Wright State University, Pharmacology and Toxicology.
Abstract
Wilhelm, Christina Marie. M.S., Department of Pharmacology and Toxicology, Wright State University, 2006. Oral LD50 of Botulinum Toxin Serotype A in Guinea Pigs. As a disease, botulism is a neuroparalytic illness resulting from the action of a potent neurotoxin produced by C. Botulinum. Of the seven distinct C. Botulinum neurotoxin serotypes: A, B, C, D, E, F, and G, only serotypes A, B, E and F cause human disease. The duration of action of the seven toxin serotypes varies with serotype A having the most sustained action (i.e. months vs. days in serotype E). This study was performed due to recently identified critical gaps in our food safety procedures. The goal of this study was to assess whether fresh 2% milk provided protective qualities to Botulinum toxin serotype A (BoNT/A) against degradation in the gastrointestinal tract. If protected this would lead to half the members of the tested population being killed with lower doses compared to toxin delivered in a conventional delivery vehicle (i.e. gel phosphate buffer). The model used for this study was adult male and female specific pathogen free Hartley guinea pigs. The pathophysiologic effects on guinea pigs following oral administration of BoNT/A was determined through daily clinical observations and utilization of telemetry implants allowing examination of changes in the mean, systolic, diastolic and pulse pressures, electrocardiogram (ECG), temperature, activity, respiratory rate, and heart rate. No difference was shown between the two treatment groups of 2% milk and gel phosphate buffer with respect to the time to first clinical sign or time to death. The LD50 of BoNT/A in 2% milk was not significantly different from BoNT/A in gel phosphate buffer indicating that the milk did not provide protective qualities in combination with the toxin.
Committee
Jason Mott (Advisor)
Pages
62 p.
Keywords
Botulinum
;
Serotype A
;
Oral LD50
;
guinea pigs
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Wilhelm, C. M. (2007).
ORAL LD50 OF BOTULINUM TOXIN SEROTYPE A IN GUINEA PIGS
[Master's thesis, Wright State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=wright1196964577
APA Style (7th edition)
Wilhelm, Christina.
ORAL LD50 OF BOTULINUM TOXIN SEROTYPE A IN GUINEA PIGS.
2007. Wright State University, Master's thesis.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=wright1196964577.
MLA Style (8th edition)
Wilhelm, Christina. "ORAL LD50 OF BOTULINUM TOXIN SEROTYPE A IN GUINEA PIGS." Master's thesis, Wright State University, 2007. http://rave.ohiolink.edu/etdc/view?acc_num=wright1196964577
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
wright1196964577
Download Count:
1,830
Copyright Info
© 2007, all rights reserved.
This open access ETD is published by Wright State University and OhioLINK.